JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 2, 2007; DOI: 10.1124/jpet.107.122606


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.122606v1
322/2/469    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakai, Y.
Right arrow Articles by Yuasa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakai, Y.
Right arrow Articles by Yuasa, H.


Received for publication March 13, 2007.
Revised April 18, 2007.
Accepted for publication May 1, 2007.

Functional characterization of human PCFT/HCP1 heterologously expressed in mammalian cells as a folate transporter

Yasuhiro Nakai 1, Katsuhisa Inoue 1, Naoki Abe 1, Mai Hatakeyama 1, Kin-ya Ohta 1, Masaki Otagiri 2, Yayoi Hayashi 3, Hiroaki Yuasa 1*

1 Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University 2 Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University 3 Department of Biopharmaceutics, College of Pharmacy, Kinjo Gakuin University

* Address correspondence to: E-mail: yuasa{at}phar.nagoya-cu.ac.jp

Abstract

The functional characteristics of human proton coupled folate transporter/heme carrier protein 1 (hPCFT/HCP1) were investigated. hPCFT/HCP1 expressed transiently in HEK293 cells mediated the transport of folate at an acidic extracellular pH of 5.5 in a manner independent of Na+ and insensitive to membrane potential. But its transport activity was absent at near neutral pH. Folate transport mediated by hPCFT/hHCP1 at pH 5.5 was saturable with a Km of 1.67 µM, and extensively inhibited by reduced folates, such as folinate, 5-methyltetrahydrofolate, as well as by MTX. sulfobromophthalein and 4,4'-diisothiocyanostilbene-2, 2'-disulfonic acid were also found to be potent inhibitors of hPCFT/hHCP1, but hemin was found to exhibit only minimal inhibitory effect. When expressed stably as a protein fused with green fluorescent protein (GFP-hPCFT/HCP1) in MDCKII cells, GFP-hPCFT/HCP1 was mainly localized at the apical membrane, and the cellular accumulation of MTX was higher from the apical side than from the basal side. These functional features of hPCFT/HCP1 are consistent with those of the well characterized carrier-mediated folate transport system in the small intestine, suggesting that hPCFT/HCP1 is responsible for the intestinal absorption of folate and also MTX. We additionally found that sulfasalazine is a potent inhibitor of hPCFT/HCP1, which would interfere with the intestinal absorption of MTX, when coadministered in therapy for rheumatoid arthritis, as well as folate.


Key words: HCP1, PCFT, folate, methotrexate, sulfasalazine, transporter


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Inoue, Y. Nakai, S. Ueda, S. Kamigaso, K.-y. Ohta, M. Hatakeyama, Y. Hayashi, M. Otagiri, and H. Yuasa
Functional characterization of PCFT/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model
Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G660 - G668.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. S. Umapathy, J. P. Gnana-Prakasam, P. M. Martin, B. Mysona, Y. Dun, S. B. Smith, V. Ganapathy, and P. D. Prasad
Cloning and Functional Characterization of the Proton-Coupled Electrogenic Folate Transporter and Analysis of Its Expression in Retinal Cell Types
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5299 - 5305.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.